福布斯华人富豪榜:38位医药人上榜 资产总额766亿美元

2017-04-18 佚名 转化医学网

4月17日,福布斯中文网发布福布斯2017华人富豪榜。其中,有38位医药人(家族)上榜,净资产总额达766亿美元。


4月17日,福布斯中文网发布福布斯2017华人富豪榜。据介绍,2017年共有486位华人富豪上榜,占全球富豪总人数的23.8%。较2015年增加116位,增幅31%。

其中,分布中国大陆、中国香港、中国台湾、新加坡、马来西亚、其他的比例为69%、14%、6%、3%、2%、6%。由此可见,中国大陆所占份额还是很大的。

从行业来看,据医药地方台统计,有38位医药人(家族)上榜。其中,进入总榜单前100强的医药人有三位:陈颂雄、赵涛(步长制药)、孙飘扬(恒瑞医药),净资产分别是86、46、43亿美元。

此外,上榜的486位华人净资产总额达13425亿美元,占全球富豪榜总资产的17.5%。其中,医药人净资产总额达766亿美元。



版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1722042, encodeId=edad1e22042a0, content=<a href='/topic/show?id=c65a465e5dc' target=_blank style='color:#2F92EE;'>#富豪榜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46575, encryptionId=c65a465e5dc, topicName=富豪榜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=163c33134913, createdName=liuli5090, createdTime=Thu Dec 21 14:32:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405417, encodeId=70ec140541e4f, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408892, encodeId=b526140889225, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469574, encodeId=1af714695e4a1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581946, encodeId=41ca1581946eb, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188526, encodeId=f04818852605, content=确实大部分是造药的, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Apr 18 14:19:46 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188525, encodeId=8b0418852575, content=请不要说是医药人!就是造药的,和医生扯什么关系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e51534610, createdName=bob.kane, createdTime=Tue Apr 18 13:49:42 CST 2017, time=2017-04-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1722042, encodeId=edad1e22042a0, content=<a href='/topic/show?id=c65a465e5dc' target=_blank style='color:#2F92EE;'>#富豪榜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46575, encryptionId=c65a465e5dc, topicName=富豪榜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=163c33134913, createdName=liuli5090, createdTime=Thu Dec 21 14:32:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405417, encodeId=70ec140541e4f, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408892, encodeId=b526140889225, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469574, encodeId=1af714695e4a1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581946, encodeId=41ca1581946eb, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188526, encodeId=f04818852605, content=确实大部分是造药的, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Apr 18 14:19:46 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188525, encodeId=8b0418852575, content=请不要说是医药人!就是造药的,和医生扯什么关系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e51534610, createdName=bob.kane, createdTime=Tue Apr 18 13:49:42 CST 2017, time=2017-04-18, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1722042, encodeId=edad1e22042a0, content=<a href='/topic/show?id=c65a465e5dc' target=_blank style='color:#2F92EE;'>#富豪榜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46575, encryptionId=c65a465e5dc, topicName=富豪榜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=163c33134913, createdName=liuli5090, createdTime=Thu Dec 21 14:32:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405417, encodeId=70ec140541e4f, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408892, encodeId=b526140889225, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469574, encodeId=1af714695e4a1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581946, encodeId=41ca1581946eb, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188526, encodeId=f04818852605, content=确实大部分是造药的, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Apr 18 14:19:46 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188525, encodeId=8b0418852575, content=请不要说是医药人!就是造药的,和医生扯什么关系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e51534610, createdName=bob.kane, createdTime=Tue Apr 18 13:49:42 CST 2017, time=2017-04-18, status=1, ipAttribution=)]
    2017-04-20 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1722042, encodeId=edad1e22042a0, content=<a href='/topic/show?id=c65a465e5dc' target=_blank style='color:#2F92EE;'>#富豪榜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46575, encryptionId=c65a465e5dc, topicName=富豪榜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=163c33134913, createdName=liuli5090, createdTime=Thu Dec 21 14:32:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405417, encodeId=70ec140541e4f, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408892, encodeId=b526140889225, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469574, encodeId=1af714695e4a1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581946, encodeId=41ca1581946eb, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188526, encodeId=f04818852605, content=确实大部分是造药的, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Apr 18 14:19:46 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188525, encodeId=8b0418852575, content=请不要说是医药人!就是造药的,和医生扯什么关系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e51534610, createdName=bob.kane, createdTime=Tue Apr 18 13:49:42 CST 2017, time=2017-04-18, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1722042, encodeId=edad1e22042a0, content=<a href='/topic/show?id=c65a465e5dc' target=_blank style='color:#2F92EE;'>#富豪榜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46575, encryptionId=c65a465e5dc, topicName=富豪榜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=163c33134913, createdName=liuli5090, createdTime=Thu Dec 21 14:32:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405417, encodeId=70ec140541e4f, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408892, encodeId=b526140889225, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469574, encodeId=1af714695e4a1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581946, encodeId=41ca1581946eb, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188526, encodeId=f04818852605, content=确实大部分是造药的, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Apr 18 14:19:46 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188525, encodeId=8b0418852575, content=请不要说是医药人!就是造药的,和医生扯什么关系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e51534610, createdName=bob.kane, createdTime=Tue Apr 18 13:49:42 CST 2017, time=2017-04-18, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1722042, encodeId=edad1e22042a0, content=<a href='/topic/show?id=c65a465e5dc' target=_blank style='color:#2F92EE;'>#富豪榜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46575, encryptionId=c65a465e5dc, topicName=富豪榜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=163c33134913, createdName=liuli5090, createdTime=Thu Dec 21 14:32:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405417, encodeId=70ec140541e4f, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408892, encodeId=b526140889225, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469574, encodeId=1af714695e4a1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581946, encodeId=41ca1581946eb, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188526, encodeId=f04818852605, content=确实大部分是造药的, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Apr 18 14:19:46 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188525, encodeId=8b0418852575, content=请不要说是医药人!就是造药的,和医生扯什么关系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e51534610, createdName=bob.kane, createdTime=Tue Apr 18 13:49:42 CST 2017, time=2017-04-18, status=1, ipAttribution=)]
    2017-04-18 1ddf0692m34(暂无匿称)

    确实大部分是造药的

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1722042, encodeId=edad1e22042a0, content=<a href='/topic/show?id=c65a465e5dc' target=_blank style='color:#2F92EE;'>#富豪榜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46575, encryptionId=c65a465e5dc, topicName=富豪榜)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=163c33134913, createdName=liuli5090, createdTime=Thu Dec 21 14:32:00 CST 2017, time=2017-12-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405417, encodeId=70ec140541e4f, content=<a href='/topic/show?id=1960e467287' target=_blank style='color:#2F92EE;'>#福布斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74672, encryptionId=1960e467287, topicName=福布斯)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iauQrVAlcY8aEJHrvOlmLCVBwvib3FD7qTK78yugrQBRibZokBC8yjXErtdo83kC7EdJjDS1azWzoDnGkrHEroiaJA/132, createdBy=bcef2544989, createdName=zhaozhouchifen, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1408892, encodeId=b526140889225, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1469574, encodeId=1af714695e4a1, content=<a href='/topic/show?id=ee4a352e18a' target=_blank style='color:#2F92EE;'>#医药人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35271, encryptionId=ee4a352e18a, topicName=医药人)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc517042865, createdName=limedical1976, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1581946, encodeId=41ca1581946eb, content=<a href='/topic/show?id=830c35868ec' target=_blank style='color:#2F92EE;'>#华人#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35868, encryptionId=830c35868ec, topicName=华人)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3f7716881423, createdName=ms4468361851264128, createdTime=Thu Apr 20 02:32:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188526, encodeId=f04818852605, content=确实大部分是造药的, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220115/46bcf39c32de4aa6b45c5f9d66c8ee77/6cb4a20c55bb4b7691122f47747bfca2.jpg, createdBy=9dad1662329, createdName=1ddf0692m34(暂无匿称), createdTime=Tue Apr 18 14:19:46 CST 2017, time=2017-04-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=188525, encodeId=8b0418852575, content=请不要说是医药人!就是造药的,和医生扯什么关系。, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70e51534610, createdName=bob.kane, createdTime=Tue Apr 18 13:49:42 CST 2017, time=2017-04-18, status=1, ipAttribution=)]
    2017-04-18 bob.kane

    请不要说是医药人!就是造药的,和医生扯什么关系。

    0

相关资讯

福布斯发布《2015美国更佳雇主500强》,百特为制药领域就职圣地

近日福布斯首次发布《2015美国最佳雇主TOP 500》榜单,互联网巨头谷歌、零售业巨头好市多(Costco Wholesale)、石油巨头马拉松石油(Marathon Petroleum)位列榜单前三甲,成为美国大众心目中最理想的就职企业。前10名的其他企业还包括:货柜商店(The Container Store)、里昂比恩(L.L.BEAN)、百特国际(Baxter International